Treatment of B-CLL With Autologous IL2 and CD40 Ligand-Expressing Tumor Cells + Lenalidomide
Phase of Trial: Phase I/II
Latest Information Update: 11 Feb 2016
At a glance
- Drugs Chronic lymphocytic leukaemia vaccine (Primary) ; Lenalidomide (Primary)
- Indications Chronic lymphocytic leukaemia
- Focus Adverse reactions; Pharmacodynamics
- Acronyms TAIL
- 07 Jun 2017 Biomarkers information updated
- 05 Feb 2016 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov record.
- 13 Mar 2013 Status changed from active, no longer recruiting to recruiting as reported by ClinicalTrials.gov.